AXSM

AXSM News

Axsome Therapeutics Shares Jump Nearly 6% as Auvelity Antidepressant Prescriptions Surge

Axsome Therapeutics (AXSM) shares rose nearly 6% in a single session following data showing a surge in prescriptions for Auvelity, the company's innovative antidepressant, signaling strong early commercial momentum for the drug.

Sep 12, 2026

Axsome Therapeutics (AXSM) Q2 Revenue Miss Raises Questions About Growth Premium as CNS Drugs Face Payer Headwinds

Axsome Therapeutics (AXSM) slightly missed Q2 revenue estimates, raising concerns that its high price-to-sales valuation may be difficult to sustain if Auvelity and Sunosi commercial ramps disappoint.

Aug 11, 2026